Performance analysis of Bicara Therapeutics (BCAX)
Annual Return
Since Sep 13, 2024, BCAX has had an average annual return of +10.47%, underperforming the benchmark SPY, which returned +18.20% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +67.27% | -3.39% | -25.59% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.18% | -0.11% | +18.53% | +8.50% | +0.79% | +36.51% | -5.19% | +67.27% | |||||
| 2025 | -27.55% | +5.38% | -2.02% | +10.28% | -35.63% | +0.43% | +19.61% | +7.46% | +32.25% | +2.91% | +14.22% | -9.32% | -3.39% |
| 2024 | +8.80% | -7.03% | -12.20% | -16.21% | -25.59% |
Drawdown analysis of Bicara Therapeutics (BCAX)
The maximum drawdown for the BCAX was -67.82%, occurring on Jun 27, 2025. Recovery took 251 trading sessions.
The current BCAX drawdown is -7.40%.
Since Sep 13, 2024 BCAX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -67.82% | Sep 17, 2024 | 194 | Jun 27, 2025 | 251 | Jun 29, 2026 | 445 |
| -10.69% | Jul 7, 2026 | 9 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -2.63% | Jun 30, 2026 | 1 | Jul 1, 2026 | 3 | Jul 7, 2026 | 4 |